Tag: Cancer Recurrence Risk

The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors

This study examines physicians’ perspectives on initiating hormone replacement therapy (HRT) in breast cancer survivors, highlighting the complexities involved in balancing the risks and benefits of treatment for managing menopausal symptoms. Given concerns about HRT potentially increasing the risk of cancer recurrence, the study explores the decision-making process of healthcare

Read More »

Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study

This 5-year prospective observational study examined the safety and efficacy of estrogen replacement therapy (ERT) in menopausal women with a history of breast carcinoma. The findings suggest that ERT did not significantly increase the risk of breast cancer recurrence while providing substantial relief from menopausal symptoms, leading to improved quality

Read More »